Prevalence and Perceived Health Associated with Insomnia Based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition Criteria: Results from the America Insomnia Survey

Abstract
No abstract available
Funding Information
  • Sanofi-Aventis
  • Aventis
  • Cephalon
  • GlaxoSmithKline
  • Merck
  • Neurocrine
  • Pfizer
  • Sanofi
  • SchoeringPlough
  • Sepracor
  • Somaxon
  • Syrex
  • Takeda
  • Transoral
  • Wyeth
  • Xenoport
  • Actelion
  • Affectis
  • AstraZeneca
  • Brainlab
  • Daimler Benz
  • Essex
  • GlaxoSmithKline
  • Lundbeck
  • Neurim
  • NeuroBiotec
  • Neurocrine
  • Novartis
  • Organon
  • Sanofi-Aventis
  • Schwarz
  • Sepracor
  • Takeda
  • UCB
  • Volkswagen
  • Weinmann
  • Wyeth
  • Pfizer
  • Sanofi-Aventis
  • Shire Development, Inc.
  • Janssen Pharmceutica
  • Pfizer
  • Sanofi-Aventis
  • Shire Development, Inc.
  • Janssen Pharmceutica
  • AstraZeneca
  • Pfizer
  • Cephalon
  • Daiichi Sankyo
  • Takeda
  • Biogen
  • Sanofi-Aventis
  • Abbott Laboratories
  • Merck
  • Novartis
  • Shire
  • Affymax
  • Adolor
  • Pfizer
  • Merck & Co.
  • Somaxon
  • Evotec
  • Actelion
  • Vanda
  • Neurogen
  • Sanofi-Aventis
  • Ventus
  • Respironics
  • Jazz Pharmaceuticals
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • GlaxoSmithKline
  • Johnson and Johnson Pharmaceuticals
  • Ortho-McNeil Pharmaceuticals, Inc.
  • Pfizer, Inc.
  • Sanofi-Aventis